Circulating Tumor DNA Assays in Clinical Cancer Research

The importance of circulating free DNA (cfDNA) in cancer clinical research was recognized in 1994 when a mutated RAS gene fragment was detected in a patient’s blood sample. Up to 1% of the total circulating DNA in patients with cancer is circulating tumor DNA (ctDNA) that originates from tumor cells...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Ossandon, Miguel R, Agrawal, Lokesh, Bernhard, Eric J, Conley, Barbara A, Dey, Sumana M, Divi, Rao L, Guan, Ping, Lively, Tracy G, McKee, Tawnya C, Sorg, Brian S, Tricoli, James V
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Commentary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136923/
https://ncbi.nlm.nih.gov/pubmed/29931312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djy105
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados